Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
Add more filters











Publication year range
1.
Life Sci ; 288: 120165, 2022 Jan 01.
Article in English | MEDLINE | ID: mdl-34822793

ABSTRACT

AIMS: Many studies have reported that the production of Lactobacillus brevis is beneficial for sleep, but the underlying mechanism remains unclear. Other known beneficial effects of Lactobacillus brevis include improvement of anxious or depressive symptoms and better modulation of the autonomic nervous system, both of which impact sleep. In this study, we investigated whether the sleep benefit of Lactobacillus brevis was associated with the modulating effects on the autonomic nervous system and anxious/depressive symptoms. MAIN METHODS: Wistar-Kyoto rats were fed the production of Lactobacillus brevis (ProGA28) for the last 2 weeks of treatment before being exposed to case exchange (stress-induced insomnia paradigm). Waking, quiet sleep, and paradoxical sleep states were defined based on polysomnographic measurements. Autonomic functioning was assessed by heart rate variability (HRV). A combined behavioral test was used to evaluate anxiety-like or depressive-like behaviors after the following 2 days. KEY FINDINGS: In exposure to the dirty cage, the control group had significant prolongation of sleep latency, sleep loss during the first 2 h, and decreased parasympathetic activity and increased sympathetic activity during quiet sleep, which were significantly mitigated in the ProGA28 group. In behavioral tests, the ProGA28 group exhibited significantly less anxiety/depression-like motor responses in the elevated plus maze test, the forced swimming test, and the three-chamber social interaction test. Less initial sleep loss in the ProGA28 group was related to higher parasympathetic activity during quiet sleep, and shorter sleep latency in both groups was associated with longer time staying in the open arm in the elevated plus maze test. SIGNIFICANCE: These findings suggest that L. brevis ProGA28 can attenuate stress-related sleep disturbance, which may be associated with increased parasympathetic activity and decreased anxiety-like behaviors.


Subject(s)
Anxiety/drug therapy , Autonomic Nervous System/drug effects , Depression/drug therapy , Levilactobacillus brevis/chemistry , Probiotics/administration & dosage , Sleep Wake Disorders/prevention & control , Stress, Physiological , Animals , Anxiety/etiology , Anxiety/pathology , Depression/etiology , Depression/pathology , Male , Rats , Rats, Inbred WKY , Sleep Wake Disorders/etiology , Sleep Wake Disorders/pathology
2.
Probiotics Antimicrob Proteins ; 12(4): 1484-1491, 2020 12.
Article in English | MEDLINE | ID: mdl-32077013

ABSTRACT

Inorganic arsenic [iAs, As(III) + As(V)] is considered a human carcinogen. Recent studies show that it has also toxic effects on the intestinal epithelium which might partly explain its systemic toxicity. The aim of this study is to evaluate the protective role of lactic acid bacteria (LAB) against the toxic effects of iAs on the intestinal epithelium. For this purpose, the human colonic cells Caco-2 were exposed to As(III) in the presence of various LAB strains or their conditioned medium. Results showed that some strains and their conditioned media partially revert the oxidative stress, the production of pro-inflammatory cytokines, the alterations of the distribution of tight junction proteins, and the cell permeability increases caused by As(III). These results show that both soluble factors secreted or resulting from LAB metabolism and cell-cell interactions are possibly involved in the beneficial effects. Therefore, some LAB strains have potential as protective agents against iAs intestinal barrier disruption.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Arsenic/toxicity , Lacticaseibacillus casei/chemistry , Lactobacillus acidophilus/chemistry , Levilactobacillus brevis/chemistry , Probiotics/pharmacology , Anti-Inflammatory Agents/chemistry , Antioxidants/chemistry , Caco-2 Cells , Cell Membrane Permeability/drug effects , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/pharmacology , Fluorescent Dyes/analysis , Fluorescent Dyes/metabolism , Gene Expression/drug effects , Humans , Interleukin-8/genetics , Interleukin-8/metabolism , Isoquinolines/analysis , Isoquinolines/metabolism , Lactobacillus acidophilus/physiology , Levilactobacillus brevis/physiology , Lacticaseibacillus casei/physiology , Oxidative Stress/drug effects , Probiotics/chemistry , Zonula Occludens-1 Protein/genetics , Zonula Occludens-1 Protein/metabolism
3.
Colloids Surf B Biointerfaces ; 186: 110734, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31865119

ABSTRACT

Recently, silver nanoparticles gain significant attention due to their applications in various fields. The aim of present study was to develop the eco-friendly, cost effective, and simple method to biosynthesized the silver nanoparticle using sliver nitrate as precursor. In this study, we investigated the physical characterization and biotechnological applications of biosynthesized silver nanoparticle using exopolysaccharide of probiotic Lactobacillus brevis MSR104 isolated from Chinese koumiss. Biosynthesized silver nanoparticles were characterized using the fourier-transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, X-ray diffraction analysis, and elemental analyzer. The achieved results indicate that silver nanoparticles varied in sized with an average size of 45 nm. The X-ray diffraction analysis results showed that the silver nanoparticles have a crystalline nature. The results of antimicrobial assay indicated that the silver nanoparticles exhibited outstanding antimicrobial activity in dose dependent manner against both Gram's negative as well as Gram's positive. The antioxidant results indicate that the silver nanoparticles showed excellent scavenging rate against DPPH free radicals (81.4 ±â€¯1.2%) and nitric oxide free radicals (75.06 ±â€¯0.4%). Furthermore, the results of MTT assay revealed that the AgNPs significantly reduced the percentage of live HT-29 cells at higher concentration. This study concluded that the newly synthesized silver nanoparticles have antibacterial, antioxidant, and anticancer applications in agricultural and food industries.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antioxidants/pharmacology , Koumiss/microbiology , Levilactobacillus brevis/metabolism , Polysaccharides/pharmacology , Anti-Bacterial Agents/biosynthesis , Anti-Bacterial Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/metabolism , Biphenyl Compounds/antagonists & inhibitors , China , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Levilactobacillus brevis/chemistry , Metal Nanoparticles/chemistry , Microbial Sensitivity Tests , Particle Size , Picrates/antagonists & inhibitors , Polysaccharides/biosynthesis , Polysaccharides/chemistry , Polysaccharides/isolation & purification , Silver/chemistry , Silver/metabolism , Surface Properties
4.
Neuropsychopharmacol Rep ; 39(2): 140-145, 2019 06.
Article in English | MEDLINE | ID: mdl-30977307

ABSTRACT

AIMS: Lactobacillus species are used widely as various food and supplements to improve health. Previous studies have shown that heat-killed Lactobacillus brevis SBC8803 induces serotonin release from intestinal cells and affects sleep rhythm and the autonomic nervous system. However, the effect of SBC8803 on cognitive function remains unknown. Here, we examined the effects of dietary heat-killed SBC8803 on hippocampus-dependent memory and adult hippocampal neurogenesis. METHODS: Hippocampus-dependent memory performance was assessed in mice fed heat-killed SBC8803 using social recognition and contextual fear conditioning tasks. Adult hippocampal neurogenesis was evaluated before, during, and after feeding heat-killed SBC8803 by measuring the number of 5-bromo-2-deoxyuridine (BrdU)-positive cells following systemic injections of BrdU using immunohistochemistry. RESULTS: Mice fed a heat-killed SBC8803 diet showed an improvement of hippocampus-dependent social recognition and contextual fear memories and enhanced adult hippocampal neurogenesis by increasing the survival, but not proliferation, of newborn neurons. CONCLUSION: Dietary heat-killed SBC8803 functions as memory and neurogenesis enhancers.


Subject(s)
Hippocampus/drug effects , Levilactobacillus brevis/chemistry , Memory , Neurogenesis , Neuroprotective Agents/pharmacology , Animals , Hippocampus/physiology , Male , Mice , Mice, Inbred C57BL
5.
Acta Crystallogr F Struct Biol Commun ; 74(Pt 12): 754-764, 2018 Dec 01.
Article in English | MEDLINE | ID: mdl-30511668

ABSTRACT

Lactobacillus brevis alcohol dehydrogenase (LbADH) is a well studied homotetrameric enzyme which catalyzes the enantioselective reduction of prochiral ketones to the corresponding secondary alcohols. LbADH is stable and enzymatically active at elevated temperatures and accepts a broad range of substrates, making it a valuable tool in industrial biocatalysis. Here, the expression, purification and crystallization of LbADH to generate large, single crystals with a volume of up to 1 mm3 suitable for neutron diffraction studies are described. Neutron diffraction data were collected from an H/D-exchanged LbADH crystal using the BIODIFF instrument at the Heinz Maier-Leibnitz Zentrum (MLZ), Garching, Germany to a resolution dmin of 2.15 Šin 16 days. This allowed the first neutron crystal structure of LbADH to be determined. The neutron structure revealed new details of the hydrogen-bonding network originating from the ion-binding site of LbADH and provided new insights into the reasons why divalent magnesium (Mg2+) or manganese (Mn2+) ions are necessary for its activity. X-ray diffraction data were obtained from the same crystal at the European Synchrotron Radiation Facility (ESRF), Grenoble, France to a resolution dmin of 1.48 Å. The high-resolution X-ray structure suggested partial occupancy of Mn2+ and Mg2+ at the ion-binding site. This is supported by the different binding affinity of Mn2+ and Mg2+ to the tetrameric structure calculated via free-energy molecular-dynamics simulations.


Subject(s)
Alcohol Dehydrogenase/chemistry , Alcohol Dehydrogenase/metabolism , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/enzymology , Alcohol Dehydrogenase/genetics , Amino Acid Sequence , Binding Sites/physiology , Crystallography, X-Ray/methods , Hydrogen Bonding , Levilactobacillus brevis/genetics , Neutron Diffraction/methods , Protein Structure, Secondary , Protein Structure, Tertiary
6.
Anal Bioanal Chem ; 410(2): 451-458, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29167934

ABSTRACT

In this work, asymmetrical flow field-flow fractionation (AF4) coupled with UV/Vis, multi-angle light scattering (MALS), and differential refractive index (dRI) detectors (AF4-UV-MALS-dRI) was employed for analysis of glutamate decarboxylase (LbGadB) from Lactobacillus brevis (L. brevis). AF4 provided molecular weight (MW) (or size)-based separation of dimer, hexamer, and aggregates of LbGadB. The effect of pH on oligomerization of LbGadB was investigated, and then AF4 results were compared to those from molecular modeling. The MWs measured by AF4-UV-MALS-dRI for dimeric and hexameric forms of LbGadB were 110 and 350 kDa, respectively, which are in good agreements with those theoretically calculated (110 and 330 kDa). The molecular sizes determined by AF4-UV-MALS-dRI were also in good agreement with those obtained from molecular modeling (6 and 10 nm, respectively, for dimeric and hexameric from AF4-UV-MALS-dRI and 6.4 × 7.6 and 7.6 × 13.1 nm from molecular modeling). The effects of temperature, salt type, and salt concentration on oligomerization of LbGadB were also investigated using dynamic light scattering (DLS). It was found that the hexameric form of LbGadB was most stable at pH 6 and in presence of NaCl or KCl. The results indicate that AF4, in combination of various online detectors mentioned above, provides an effective tool for monitoring of oligomerization of LbGadB under different conditions, such as temperature, pH, type of salts, and salt concentrations.


Subject(s)
Glutamate Decarboxylase/chemistry , Levilactobacillus brevis/enzymology , Dynamic Light Scattering , Enzyme Stability , Fractionation, Field Flow , Hydrogen-Ion Concentration , Levilactobacillus brevis/chemistry , Models, Molecular , Protein Multimerization , Refractometry , Salts/chemistry , Temperature
7.
Int J Biol Macromol ; 107(Pt A): 874-881, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28939514

ABSTRACT

Despite several hurdles, which hinder bacterial growth in beer, certain bacteria are still able to spoil beer. One type of spoilage is characterized by an increased viscosity and slimy texture caused by exopolysaccharide (EPS) formation of lactic acid bacteria (LAB). In this study, we characterize for the first time EPS production in a beer-spoiling strain (TMW 1.2112) of Lactobacillus brevis, a species commonly involved in beer spoilage. The strain's growth dynamics were assessed and we found an increased viscosity or ropiness in liquid or on solid media, respectively. Capsular polysaccharides (CPS) and released EPS from the cells or supernatant, respectively, were analyzed via NMR spectroscopy and methylation analysis. Both are identical ß-(1→3)-glucans, which are ramified with ß-glucose residues at position O2. Therefore, we assume that this EPS is mainly produced as CPS and partially released into the surrounding medium, causing viscosity of e.g. beer. CPS formation was confirmed via an agglutination test. A plasmid-located glycosyltransferase-2 was found as responsible for excess ß-glucan formation, chromosomal glucanases were proposed for its degradation. The glycosyltransferase-2 gene could also be specifically identified in beer-spoiling, slime-producing Lactobacillus rossiae and Lactobacillus parabuchneri strains, suggesting it as promising marker gene for the early detection of ß-glucan-producing Lactobacilli in breweries.


Subject(s)
Beer/microbiology , Levilactobacillus brevis/chemistry , Polysaccharides/biosynthesis , beta-Glucans/chemistry , Food Microbiology , Glucose/chemistry , Glycosyltransferases/chemistry , Glycosyltransferases/genetics , Levilactobacillus brevis/genetics , Levilactobacillus brevis/growth & development , Magnetic Resonance Spectroscopy , Polysaccharides/chemistry , Polysaccharides/genetics , Viscosity , beta-Glucans/isolation & purification
8.
Probiotics Antimicrob Proteins ; 10(1): 98-109, 2018 03.
Article in English | MEDLINE | ID: mdl-28752423

ABSTRACT

In this study, seven bacteriocinogenic and non-bacteriocinogenic LAB strains previously isolated from the intestines of Nile tilapia and common carp and that showed potent antibacterial activity against host-derived and non-host-derived fish pathogens were assayed for their probiotic and safety properties so as to select promising candidates for in vivo application as probiotic in aquaculture. All the strains were investigated for acid and bile tolerances, transit tolerance in simulated gastrointestinal conditions, for cell surface characteristics including hydrophobicity, co-aggregation and auto-aggregation, and for bile salt hydrolase activity. Moreover, haemolytic, gelatinase and biogenic amine-producing abilities were investigated for safety assessment. The strains were found to be tolerant at low pH (two strains at pH 2.0 and all the strains at pH 3.0). All of them could also survive in the presence of bile salts (0.3% oxgall) and in simulated gastric and intestinal juices conditions. Besides, three of them were found to harbour the gtf gene involved in pH and bile salt survival. The strains also showed remarkable cell surface characteristics, and 57.14% exhibited the ability to deconjugate bile salts. When assayed for their safety properties, the strains prove to be free from haemolytic activity, gelatinase activity and they could neither produce biogenic amines nor harbour the hdc gene. They did not also show antibiotic resistance, thus confirming to be safe for application as probiotics. Among them, Lactobacillus brevis 1BT and Lactobacillus plantarum 1KMT exhibited the best probiotic potentials, making them the most promising candidates.


Subject(s)
Carps/microbiology , Cichlids/microbiology , Fish Diseases/prevention & control , Intestines/microbiology , Lactobacillales/isolation & purification , Probiotics/chemistry , Animals , Aquaculture , Drug Evaluation, Preclinical , Fish Diseases/microbiology , Hydrophobic and Hydrophilic Interactions , Lactobacillales/chemistry , Lactobacillales/classification , Lactobacillales/genetics , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/classification , Levilactobacillus brevis/genetics , Levilactobacillus brevis/isolation & purification , Lactobacillus plantarum/chemistry , Lactobacillus plantarum/classification , Lactobacillus plantarum/genetics , Lactobacillus plantarum/isolation & purification , Phylogeny , Probiotics/adverse effects , Probiotics/classification , Probiotics/isolation & purification
9.
Food Chem ; 242: 45-52, 2018 Mar 01.
Article in English | MEDLINE | ID: mdl-29037713

ABSTRACT

Cereal-associated Lactic Acid Bacteria (LAB) are well known for homopolymeric exopolysaccharide (EPS) production. Herein, the structure of an EPS isolated from sourdough isolate Lactobacillus brevis E25 was determined. A modified BHI medium was used for production of EPS-E25 in order to eliminate potential contaminants. Analysis of sugar monomers in EPS revealed that glucose was the only sugar present. Structural characterisation of EPS by NMR and methylation analysis revealed that E25 produced a highly branched α-glucan with (α1→3) and (α1→6) glycosidic linkages, and was similar in structure to a previously reported EPS from Lactobacillus reuteri 180. The 1H and 13C NMR data were contrasted with newly recorded data for known polysaccharides (alternan, commercial dextran) which also contain α-(1,3,6)Glc branch points. It was found in both E25 EPS and alternan that NMR parameters could be used to distinguish glucose residues that had the same substitution pattern but occupied different positions in the structure.


Subject(s)
Glucans/chemistry , Levilactobacillus brevis/chemistry , Polysaccharides, Bacterial/chemistry , Dextrans/chemistry , Edible Grain/chemistry , Limosilactobacillus reuteri/chemistry , Magnetic Resonance Spectroscopy
10.
Braz. j. microbiol ; Braz. j. microbiol;48(4): 740-746, Oct.-Dec. 2017. tab, graf
Article in English | LILACS | ID: biblio-889173

ABSTRACT

ABSTRACT The spoilage of beer by bacteria is of great concern to the brewer as this can lead to turbidity and abnormal flavors. The polymerase chain reaction (PCR) method for detection of beer-spoilage bacteria is highly specific and provides results much faster than traditional microbiology techniques. However, one of the drawbacks is the inability to differentiate between live and dead cells. In this paper, the combination of propidium monoazide (PMA) pretreatment and conventional PCR had been described. The established PMA-PCR identified beer spoilage Lactobacillus brevis based not on their identity, but on the presence of horA gene which we show to be highly correlated with the ability of beer spoilage LAB to grow in beer. The results suggested that the use of 30 µg/mL or less of PMA did not inhibit the PCR amplification of DNA derived from viable L. brevis cells. The minimum amount of PMA to completely inhibit the PCR amplification of DNA derived from dead L. brevis cells was 2.0 µg/mL. The detection limit of PMA-PCR assay described here was found to be 10 colony forming units (CFU)/reaction for the horA gene. Moreover, the horA-specific PMA-PCR assays were subjected to 18 reference isolates, representing 100% specificity with no false positive amplification observed. Overall the use of horA-specific PMA-PCR allows for a substantial reduction in the time required for detection of potential beer spoilage L. brevis and efficiently differentiates between viable and nonviable cells.


Subject(s)
Staining and Labeling/methods , Beer/microbiology , Levilactobacillus brevis/isolation & purification , Levilactobacillus brevis/growth & development , Real-Time Polymerase Chain Reaction/methods , Propidium/analogs & derivatives , Propidium/chemistry , Azides/chemistry , Levilactobacillus brevis/genetics , Levilactobacillus brevis/chemistry , Real-Time Polymerase Chain Reaction/instrumentation , Food Microbiology
11.
J Agric Food Chem ; 65(42): 9324-9332, 2017 Oct 25.
Article in English | MEDLINE | ID: mdl-28965394

ABSTRACT

Casein from ovine and bovine milk were hydrolyzed with two extracellular protease preparations from Lactobacillus brevis and Lactococcus lactis. The hydrolysates were analyzed by HPLC-MS/MS for peptide identification. A strain-dependent peptide profile could be observed, regardless of the casein origin, and the specificity of these two proteases could be computationally ascribed. The cleavage pattern yielding phenylalanine, leucine, or tyrosine at C-terminal appeared both at L. lactis and Lb. brevis hydrolysates. However, the cleavage C-terminal to lysine was favored with Lb. brevis protease. The hydrolysates showed ACE-inhibitory activity with IC50 in the 16-70 µg/mL range. Ovine casein hydrolysates yielded greater ACE-inhibitory activity. Previously described antihypertensive and opioid peptides were found in these ovine and bovine casein hydrolysates and prediction of the antihypertensive activity of the sequences based on quantitative structure and activity relationship (QSAR) was performed. This approach might represent a useful classification tool regarding health-related properties prior to further purification.


Subject(s)
Bacterial Proteins/chemistry , Caseins/chemistry , Lactococcus lactis/enzymology , Levilactobacillus brevis/enzymology , Peptide Hydrolases/chemistry , Peptides/chemistry , Amino Acid Sequence , Angiotensin-Converting Enzyme Inhibitors/chemistry , Animals , Bacterial Proteins/metabolism , Biocatalysis , Levilactobacillus brevis/chemistry , Lactococcus lactis/chemistry , Milk/chemistry , Molecular Sequence Data , Peptide Hydrolases/metabolism , Peptide Mapping , Sheep , Substrate Specificity , Tandem Mass Spectrometry
12.
J Appl Microbiol ; 123(2): 535-543, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28632956

ABSTRACT

AIMS: Atopic dermatitis (AD) is an allergic skin disease driven by the Th2-prone immune response. Therefore, a fundamental approach to restoring the Th1/Th2 balance is needed to treat AD. METHODS AND RESULTS: Eighteen different Lactobacillus strains isolated from Kimchi were screened to identify those that stimulated immune cells to secret Th1-type or Th2-type cytokines. Lactobacillus brevis NS1401 induced the greatest IFN-γ and IL-12 secretion and the least IL-4 production among the tested Lactobacillus strains. Furthermore, oral administration of heat-killed NS1401 ameliorated the symptoms of dust mite-induced AD in NC/Nga mice by decreasing the serum IgE level and reducing the number of mast cells and eosinophils in lesions. Also, the size and number of cells in the draining lymph nodes of NS1401-administered mice were significantly reduced. In agreement with these results, secretion of a Th1-type cytokine (IFN-γ) and allergen-specific IgG2a were increased, whereas secretion of Th2-type cytokines (IL-4, IL-5, and IL-10) and allergen-specific IgG1 were decreased upon administration of NS1401 in mice. CONCLUSIONS: Lactobacillus brevis NS1401 alleviates the symptoms of AD by restoring the Th1/Th2 balance through enhancing Th1-prone immunity. SIGNIFICANCE AND IMPACT OF THE STUDY: The immunomodulatory function of L. brevis NS1401 may provide effective new therapeutics against AD.


Subject(s)
Brassica/microbiology , Dermatitis, Atopic/microbiology , Levilactobacillus brevis/immunology , Probiotics/administration & dosage , Pyroglyphidae/immunology , Animals , Dermatitis, Atopic/immunology , Female , Hot Temperature , Humans , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-12/genetics , Interleukin-12/immunology , Interleukin-4/immunology , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/isolation & purification , Levilactobacillus brevis/physiology , Mice , Mice, Inbred C57BL , Probiotics/chemistry , Skin/pathology , Th2 Cells/immunology
13.
Braz J Microbiol ; 48(4): 740-746, 2017.
Article in English | MEDLINE | ID: mdl-28633981

ABSTRACT

The spoilage of beer by bacteria is of great concern to the brewer as this can lead to turbidity and abnormal flavors. The polymerase chain reaction (PCR) method for detection of beer-spoilage bacteria is highly specific and provides results much faster than traditional microbiology techniques. However, one of the drawbacks is the inability to differentiate between live and dead cells. In this paper, the combination of propidium monoazide (PMA) pretreatment and conventional PCR had been described. The established PMA-PCR identified beer spoilage Lactobacillus brevis based not on their identity, but on the presence of horA gene which we show to be highly correlated with the ability of beer spoilage LAB to grow in beer. The results suggested that the use of 30µg/mL or less of PMA did not inhibit the PCR amplification of DNA derived from viable L. brevis cells. The minimum amount of PMA to completely inhibit the PCR amplification of DNA derived from dead L. brevis cells was 2.0µg/mL. The detection limit of PMA-PCR assay described here was found to be 10 colony forming units (CFU)/reaction for the horA gene. Moreover, the horA-specific PMA-PCR assays were subjected to 18 reference isolates, representing 100% specificity with no false positive amplification observed. Overall the use of horA-specific PMA-PCR allows for a substantial reduction in the time required for detection of potential beer spoilage L. brevis and efficiently differentiates between viable and nonviable cells.


Subject(s)
Beer/microbiology , Levilactobacillus brevis/growth & development , Levilactobacillus brevis/isolation & purification , Real-Time Polymerase Chain Reaction/methods , Staining and Labeling/methods , Azides/chemistry , Food Microbiology , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/genetics , Propidium/analogs & derivatives , Propidium/chemistry , Real-Time Polymerase Chain Reaction/instrumentation
14.
J Trace Elem Med Biol ; 40: 1-9, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28159215

ABSTRACT

The present study was designed to isolate a highly selenium-tolerant lactobacillus strain from an Iranian traditional dairy product named as Spar. Different criteria such as tolerance to the low pH, simulated gastric juice (SGJ), simulated intestinal juice (SIJ) and bile salts tolerance as well as Caco-2 cell adhesion assay were examined to evaluate the probiotic potentials of the selected isolate. Furthermore, the antioxidant properties of the isolate cultivated in medium containing and free of SeO32- ions were evaluated using DPPH scavenging and reducing power assays. The isolate was identified using conventional identification and 16S rDNA gene sequencing methods as Lactobacillus brevis LSe. The obtained results showed that the isolate was able to tolerate high concentration of sodium selenite (3.16mM). By decreasing the pH of the SGJ from 6 to 3, the survival percent of L. brevis LSe was not significantly changed over the time (p>0.05). In addition, the survival percent of the isolate in the SIJ (pH 6 and pH 8) was not statistically altered after 3h, 6h and 24h of incubation (p>0.05). In the presence of bile salts (0.3% and 0.6%) the survival rate of L. brevis LSe was not significantly decreased (p>0.05).L. brevis LSe also demonstrated the satisfactory ability to adhere to Caco-2 cells which were similar to that of the reference strain L. plantarum. The obtained results of antioxidant evaluation showed that L. brevis LSe containing elemental Se exhibited significantly higher radical scavenging ability (36.5±1.31%) and reducing power (OD700, 0.14) than L. brevis LSe cultured in selenite-free medium (p<0.05). To sum up, further investigations should be conducted to merit the probable potential health benefit of Se-enriched L. brevis LSe and its application as Se-containing supplements or fermented foods.


Subject(s)
Antioxidants/metabolism , Dairy Products/microbiology , Levilactobacillus brevis/isolation & purification , Levilactobacillus brevis/metabolism , Probiotics , Selenium/metabolism , Caco-2 Cells , Cell Adhesion/drug effects , Humans , Iran , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/drug effects , Selenium/pharmacology
15.
Benef Microbes ; 8(1): 121-131, 2017 Feb 07.
Article in English | MEDLINE | ID: mdl-27824277

ABSTRACT

Commensal skin microbiota plays an important role in both influencing the immune response of the skin and acting as a barrier against colonisation of potentially pathogenic microorganisms and overgrowth of opportunistic pathogens. Staphylococcus epidermidis is a key constituent of the normal microbiota on human skin. It balances the inflammatory response after skin injury and produces antimicrobial molecules that selectively inhibit skin pathogens. Here we describe Lactobacillus brevis DSM17250 that was identified among hundreds of Lactobacillus strains to exhibit an anti-inflammatory effect in human keratinocytes in vitro and specific stimulatory impact on the growth of S. epidermidis. The aqueous cell-free extract of L. brevis DSM17250 was used in an ointment formulation and tested in a randomized placebo-controlled double blinded human pilot study. Healthy volunteers with diagnosed dry skin were treated for four weeks. The study data shows that L. brevis DSM17250 extract induces re-colonisation of the skin by protective commensal microorganisms as judged from selective bacterial cultivation of surface-associated skin microorganism of the lower leg. Furthermore, the 4 week administration of the L. brevis DSM17250 extract significantly improved the transepidermal water loss value (TEWL), reduced the xerosis cutis symptoms and stinging. The data shows that daily application of L. brevis DSM17250 extract in a topical product significantly improves the microbial skin microbiota by promoting the growth of species which possess beneficial regulatory and protective properties such as S. epidermidis. Restoring the natural skin microbiota leads to significantly improved skin barrier function (as transepidermal water loss) and decrease of xeroderma (xerosis cutis) symptoms (as measured by dry skin area and severity index, DASI). We propose that improving and stabilizing the natural skin microbiota by specifically stimulating the growth of S. epidermidis is an important and novel concept to manage skin diseases associated with microbiota dysbiosis.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Levilactobacillus brevis/chemistry , Microbiota , Ointments/administration & dosage , Skin Diseases/prevention & control , Staphylococcus epidermidis/growth & development , Adult , Double-Blind Method , Female , Humans , Male , Middle Aged , Pilot Projects , Placebos , Skin/microbiology , Skin Diseases/microbiology , Treatment Outcome
16.
Int J Biol Macromol ; 95: 1004-1010, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27984145

ABSTRACT

In this work, some important characteristics of surface layer (S-layer) proteins extracted from two new and native Lactobacillus strains, L.brevis KM3 and L.brevis KM7, were investigated. The presence of S-layer on the external surface of L.brevis KM3 was displayed by thin sectioning and negative staining. SDS-PAGE analysis were shown same dominant protein bands approximately around 48kDa for both S-layer proteins. Moreover, the S-layer reappeared when LiCl treated cells were allowed to grow again. Protein secondary structure and thermal behavior were evaluated by using circular dichroism (CD) and differential scanning calorimetry (DSC), respectively. Both S-layer proteins had high content of ß-sheet and low amount of α-helix. The thermograms of lyophilized S-layer proteins of L.brevis KM3 and L.brevis KM7 showed one transition peak at 67.9°C and 59.14°C, respectively. To determine monodispersity of extracted S-layer proteins, dynamic light scattering (DLS) was used. The results indicated that the main population of S-layer molecules in two tested lactobacillus strains were composed of monomer with an expected diameter close to 10nm. Furthermore, Zeta potential measurements were showed positive potential for both S-layer proteins, as expected. Our results could be used as the basis for biotechnological applications of these two new S-layer proteins.


Subject(s)
Bacterial Proteins/isolation & purification , Cell Wall/chemistry , Levilactobacillus brevis/chemistry , Membrane Glycoproteins/isolation & purification , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Cell Wall/genetics , Cell Wall/metabolism , Cell Wall/ultrastructure , Electrophoresis, Polyacrylamide Gel , Freeze Drying , Gene Expression , Levilactobacillus brevis/genetics , Levilactobacillus brevis/metabolism , Levilactobacillus brevis/ultrastructure , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/genetics , Microtomy , Protein Structure, Secondary , Staining and Labeling
17.
Sci Rep ; 6: 27779, 2016 06 13.
Article in English | MEDLINE | ID: mdl-27292129

ABSTRACT

Tyrosine decarboxylase (TDC) is a pyridoxal 5-phosphate (PLP)-dependent enzyme and is mainly responsible for the synthesis of tyramine, an important biogenic amine. In this study, the crystal structures of the apo and holo forms of Lactobacillus brevis TDC (LbTDC) were determined. The LbTDC displays only 25% sequence identity with the only reported TDC structure. Site-directed mutagenesis of the conformationally flexible sites and catalytic center was performed to investigate the potential catalytic mechanism. It was found that H241 in the active site plays an important role in PLP binding because it has different conformations in the apo and holo structures of LbTDC. After binding to PLP, H241 rotated to the position adjacent to the PLP pyridine ring. Alanine scanning mutagenesis revealed several crucial regions that determine the substrate specificity and catalytic activity. Among the mutants, the S586A variant displayed increased catalytic efficiency and substrate affinity, which is attributed to decreased steric hindrance and increased hydrophobicity, as verified by the saturation mutagenesis at S586. Our results provide structural information about the residues important for the protein engineering of TDC to improve catalytic efficiency in the green manufacturing of tyramine.


Subject(s)
Levilactobacillus brevis/enzymology , Mutagenesis, Site-Directed/methods , Tyrosine Decarboxylase/chemistry , Tyrosine Decarboxylase/metabolism , Alanine/genetics , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Catalytic Domain , Crystallography, X-Ray , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/genetics , Molecular Docking Simulation , Protein Binding , Protein Conformation , Pyridoxal Phosphate/metabolism , Substrate Specificity , Tyrosine Decarboxylase/genetics
18.
Anticancer Res ; 36(2): 591-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26851013

ABSTRACT

Although probiotics are known to have antitumor activity, few bacteria-derived antitumor molecules have been identified. The present study explored an antitumor molecule derived from Lactobacillus brevis SBL8803 (L. brevis 8803) and the mechanisms that underlie its effects. Cell viability and apoptosis were assessed by a sulforhodamine B assay and terminal deoxynucleotidyl transferase dUTP staining, respectively. Phosphorylated extracellular signal-regulated kinase (ERK) and cleaved poly ADP-ribose polymerase (PARP) expression were detected by western blotting. The conditioned medium of L. brevis 8803 inhibited SW620 cells viability and the effect was reduced by the degradation of polyphosphate (poly P) in the conditioned medium. A xenograft model showed that poly P inhibited the growth of SW620 cells. Poly P induced the apoptosis of SW620 cells through activation of the ERK pathway. In contrast, in primary cultured cells derived from normal mouse, poly P did not affect cell viability. Probiotic-derived poly P is expected to be an antitumor drug with fewer adverse effects than conventional drugs.


Subject(s)
Apoptosis/drug effects , Colonic Neoplasms/drug therapy , Colonic Neoplasms/pathology , Culture Media, Conditioned/pharmacology , Levilactobacillus brevis/chemistry , Polyphosphates/pharmacology , Animals , Blotting, Western , Cell Proliferation/drug effects , Disease Progression , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Phosphorylation/drug effects , Signal Transduction/drug effects , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
19.
Nat Commun ; 6: 7661, 2015 Jul 22.
Article in English | MEDLINE | ID: mdl-26198469

ABSTRACT

Energy-coupling factor (ECF) transporters are a new family of ABC transporters that consist of four subunits, two cytoplasmic ATPases EcfA and EcfA' and two transmembrane proteins namely EcfS for substrate-specific binding and EcfT for energy coupling. Here, we report the 3.2-Å resolution crystal structure of the EcfS protein of a folate ECF transporter from Enterococcus faecalis-EfFolT, a close homologue of FolT from Lactobacillus brevis-LbFolT. Structural and biochemical analyses reveal the residues constituting the folate-binding pocket and determining the substrate-binding specificity. Structural comparison of the folate-bound EfFolT with the folate-free LbFolT contained in the holotransporter complex discloses significant conformational change at the L1 loop, and reveals a gating mechanism of ECF transporters in which the L1 loop of EcfS acts as a gate in the substrate binding and release.


Subject(s)
Bacterial Proteins/metabolism , Enterococcus faecalis/metabolism , Bacterial Proteins/chemistry , Enterococcus faecalis/chemistry , Folic Acid/metabolism , Levilactobacillus brevis/chemistry , Levilactobacillus brevis/metabolism , Protein Conformation
20.
Transl Res ; 166(2): 163-75, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25766132

ABSTRACT

Inflammatory bowel disease frequently causes intestinal obstruction because of extensive fibrosis. This study investigated whether polyphosphate (poly P), an active molecule derived from Lactobacillus brevis, could improve the fibrosis in a model of chronic colitis. In this study, dextran sodium sulfate (DSS)-induced chronic colitis models and trinitrobenzene sulfonic acid (TNBS)-induced colitis models were used as models of fibrosis. To clarify the mechanism responsible for the observed effects, Caco-2/brush border epithelial (BBE) and naive T helper lymphocyte (THP)-1 cells were treated with lipopolysaccharide (LPS) to induce inflammation. Non-cancer human colon fibroblast (CCD-18) cells were treated with transforming growth factor beta 1 (TGF-ß1) to induce fibrosis. The expression levels of fibrosis- and inflammation-associated molecules were evaluated by both a Western blotting analysis and reverse transcriptase-polymerase chain reaction (RT-PCR). The histologic inflammation and fibrosis were significantly improved in the group administered poly P in both the DSS and TNBS colitis models. The levels of interleukin 1ß (IL-1ß) and tumor necrosis factor α (TNF-α) were significantly decreased by poly P treatment. The expression levels of TGF-ß1 and collagens in the colitis mice were decreased by poly P. The LPS-induced expressions of IL-1ß and TGF-ß1 in Caco-2/BBE cells and of TNF-α in THP-1 cells were reduced by poly P treatment. Poly P did not affect the expression of collagens and connective tissue growth factor in the CCD-18 cells. In conclusion, poly P suppresses intestinal inflammation and fibrosis by downregulating the expression of inflammation- and fibrosis-associated molecules in the intestinal epithelium. The administration of poly P is therefore a novel option to treat fibrosis because of chronic intestinal inflammation.


Subject(s)
Colitis/drug therapy , Colon/pathology , Levilactobacillus brevis/chemistry , Polyphosphates/therapeutic use , Probiotics/therapeutic use , Animals , Caco-2 Cells , Chronic Disease , Colitis/chemically induced , Colitis/pathology , Collagen/metabolism , Colon/drug effects , Connective Tissue Growth Factor/metabolism , Cytokines/metabolism , Dextran Sulfate , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fibrosis , Humans , Inflammation/pathology , Inflammation Mediators/metabolism , Macrophages/drug effects , Macrophages/metabolism , Macrophages/pathology , Mice, Inbred C57BL , Polyphosphates/pharmacology , Probiotics/pharmacology , Transforming Growth Factor beta1/metabolism , Trinitrobenzenesulfonic Acid , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL